MINNEAPOLIS, July 30, 2012 /PRNewswire/ -- Cardiocom, a leading provider of telehealth products and services recently learned that Robert Bosch Healthcare Systems, Inc. has alleged that Cardiocom is infringing certain patent rights.
Daniel L. Cosentino, Cardiocom's President and Chief Executive Officer said, "Bosch's claims are groundless and completely without merit. Cardiocom's products and services do not violate any intellectual property rights. Cardiocom is being advised by one of the nation's most prominent and highly respected patent law firms." Cardiocom's intellectual property portfolio includes over 160 claims, as specified in U.S. Patent Nos. 6290646, 6454705, 6723045, 6755783, 7945451, 7577475, 7736318, and dates back to at least 1999.
Cardiocom customers will not be impacted in any way by these matters. Cardiocom will continue to deliver innovative quality driven telehealth services, state-of-the-art products, and unparalleled customer care for which Cardiocom is known.
Cardiocom®, Experts in TelehealthSM, is an award-winning leader in innovative home telehealth solutions. Founded in 1998, Cardiocom develops, manufactures and markets its own telehealth devices for heart failure, diabetes, hypertension, COPD, asthma and other chronic conditions. Cardiocom's clients include some of the most respected home health groups, health plans, hospitals, physician groups, and coordinated care companies in the nation. Through these established relationships, Cardiocom improves the lives of thousands of people each day. For more information on Cardiocom and its services, call 888-243-8881 or visit www.cardiocom.com.